Among these, 10 target genes (ACE2, HTR1A, HTR2A, AKT1, PKIA, CREB1, BDNF, BCL2, BAX, and CASP3), with higher degree were recognized as the major hub targets of XPF in treating CHD with depression. Here, HTR1A is linked to depressive symptom measurement.